A5005103393- Acute Ischemic Stroke Management
- Venous Thromboembolism Diagnosis and Management
- Stroke Rehabilitation and Recovery
- Cerebrovascular and Carotid Artery Diseases
- Traumatic Brain Injury and Neurovascular Disturbances
- Healthcare Systems and Practices
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Diagnosis and treatment of tuberculosis
- Acute Kidney Injury Research
- Muscle and Compartmental Disorders
- Protease and Inhibitor Mechanisms
- Cerebrospinal fluid and hydrocephalus
- Congenital gastrointestinal and neural anomalies
- Esophageal and GI Pathology
- Moyamoya disease diagnosis and treatment
- Atrial Fibrillation Management and Outcomes
- Sarcoidosis and Beryllium Toxicity Research
- Clinical practice guidelines implementation
- Trauma and Emergency Care Studies
- Infectious Diseases and Tuberculosis
- Intracerebral and Subarachnoid Hemorrhage Research
- Congenital Anomalies and Fetal Surgery
- Angiogenesis and VEGF in Cancer
Centre Hospitalier de Perpignan
2013-2024
Background and purpose Inter-hospital transfer for mechanical thrombectomy (MT) might result in the of patients who finally will not undergo MT (ie, futile transfers [FT]). This study evaluated FT frequency a primary stroke center (PSC) semi-rural area at 156 km from comprehensive (CSC). Methodology Retrospective analysis data collected 6-year prospective registry concerning admitted to our PSC within 4.5 hours acute ischemic (AIS) symptom onset, with MR angiography indicating presence large...
The purpose of this study was to demonstrate that the median door-to-needle (DTN) time for intravenous tissue plasminogen activator (tPA) treatment can be reduced 45 min in a primary stroke centre with MRI-based screening acute ischaemic (AIS).From February 2015 2017, unit Perpignan general hospital, France, implemented quality-improvement (QI) process. During period, patients who received tPA within 4.5 h after AIS onset were included QI cohort. Their clinical characteristics and timing...
<b><i>Introduction:</i></b> The current guidelines advocate the implementation of stroke networks to organize endovascular treatment (ET) for patients with acute ischemic due large vessel occlusion (LVO) after transfer from a Primary Stroke Centre (PSC) Comprehensive (CSC). In France and in many other countries around world, these transfers are carried out by physician-led mobile medical team. However, recent broadening ET indications, their availability is becoming...
Purpose: Few data are available on complications occurring during inter-hospital transfer from a primary stroke center (PSC) to comprehensive (CSC) for endovascular treatment (EVT) after large vessel occlusion (LVO). Therefore, we prospectively studied consecutive patients transferred our PSC the next CSC 4 years determine incidence and risk factors of transfer. Methods: This observational, single-center study included January 1, 2015 December 31, 2018. During transfer, all medical incidents...
Too few patients benefit from endovascular therapy (EVT) in large vessel occlusion acute stroke (LVOS), and various care paradigms are currently investigated to reduce these inequalities health access. We aimed investigate whether newly set-up thrombectomy-capable centers (TSC) offered a safe, effective cost-effective procedure.